Key facts
- It has raised $5.8M across 1 recorded rounds; the latest was Seed Round ($4.3M) in Aug 2025.
- Notable investors include Innovation Authority, Consensus Business Group, Broadfin Capital, Boston Scientific, Edge Medical Ventures — 8 tracked in total.
- Synchrony Medical has filed 2 Form Ds with the SEC since 2025, most recently Mar 2026 ($4.3M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Synchrony Medical
Funding rounds
1 roundsAbout Synchrony Medical
Developer of a respiratory therapy device designed to provide treatment for chronic obstructive pulmonary disease (COPD). The company's device provides remote monitoring and treatment of COPD patients, which involves manual respiratory physiotherapy, enabling patients to have tailored, adaptive home therapy for improving lung function and clearing their airways.
- Sector
- Healthcare
- HQ
- Jersey City, NJ, United States
- Founded
- 2020
- Employees
- 9
- Website
- libairty.health/
- Ownership
- Privately Held (backing)
Synchrony Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synchrony Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synchrony Medical in its N-PORT filings yet. We sweep new filings monthly.